Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
NeuroFrontiersSpinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
The Convergence"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
Finerenone for CKD in Type 1 Diabetes: Updates from FINE-ONE
Heart MattersFinerenone for CKD in Type 1 Diabetes: Updates from FINE-ONE
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
NephrologyIndividualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Finerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
NephrologyFinerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
Implications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
NephrologyImplications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
- advertisement
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
CME/CEStuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
The 4-Hit Hypothesis: Foundations of IgAN Pathogenesis
MinuteCE®The 4-Hit Hypothesis: Foundations of IgAN Pathogenesis
Mechanism-Based Targeting: Why APRIL Matters in IgAN
MinuteCE®Mechanism-Based Targeting: Why APRIL Matters in IgAN
- advertisement
Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
Medical Industry FeatureChallenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
The Role of APRIL and the 4-Hit Process in the Pathogenesis of IgA Nephropathy
Medical Industry FeatureThe Role of APRIL and the 4-Hit Process in the Pathogenesis of IgA Nephropathy
Navigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study
Medical Industry FeatureNavigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study
Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression
Medical Industry FeatureExpert Opinions on Characteristics of Patients With C3G at High Risk of Progression
Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression
Medical Industry FeatureExpert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression
Expert Opinions on Renal Compensation and Renal Functional Reserve
Medical Industry FeatureExpert Opinions on Renal Compensation and Renal Functional Reserve
- 03/16/2026
- 03/13/2026
- 03/09/2026
- 03/09/2026
- 03/09/2026
- 03/05/2026





















































































